Cite
HARVARD Citation
Saad, F. et al. (2018). Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial. Lancet oncology. 19 (10), pp. 1404-1416. [Online].